Gate2Brain
patented technology based on peptides (small proteins) that efficiently cross biological barriers, such as the blood-brain barrier that protects the brain
Gate2Brain has raised €9.5M across 2 funding rounds from 1 investor, most recently a round in Jun 2026. Based in Barcelona, Spain; active in Healthtech. Data as of 28 Oct 2026.
Barcelona, Spaingate2brain.com ↗
Total raised
€9.5M
€9,500,000
Funding rounds
2
Investors
1
distinct backers
Active since
2022-12
latest 2026-06
Funding by year
EUR raised per year · 2026 YTDGate2Brain — funding by year — interactive chart.
Data table
| Gate2Brain — funding by year | |
|---|---|
| 2022 | €2.5M |
| 2026 | €7.0M |
Signals
Medium confidenceRaise-next likelihood24
base rate 30% for Other
- ▼ Raised very recently
- ▲ Up-round momentum
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-06-18 | Other | €7.0M | — | View deal → |
| 2022-12-21 | Other | €2.5M | EIC Accelerator | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData